Reduced CHD5 mRNA expression was significantly associated with lymph node metastasis, while reduced CHD5 protein expression significantly correlated to recurrence, distant metastasis, progression-free survival and overall survival in breast cancer. The gene discussed is CHD5; the disease is metastatic malignant neoplasm in the lymph nodes.